Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery Solutions

Gate2Brain showcased its cutting-edge peptide-based technology at BioJapan 2025 in Yokohama, strengthening its connections within the Japanese pharma ecosystem and contributing to global discussions on innovative brain delivery solutions.

Gate2Brain participated in BioJapan 2025, held from October 8–10 at Pacifico Yokohama, Japan — one of the leading partnering events for the global biotechnology industry.

This year’s edition brought together over 18,000 attendees and more than 1,100 exhibitors from over 30 countries, highlighting the event’s global reach and focus on innovation in regenerative medicine, biopharmaceuticals, and digital health.

Gate2Brain was present with an exhibition booth, engaging with visitors and partners to share its advances in peptide-based brain delivery technology. The company joined once again to connect with the Japanese pharma ecosystem, explore new collaboration opportunities, and exchange knowledge with international peers.

During the event, Dr. Meritxell Teixidó, Gate2Brain’s CEO, presented “Gate2Brain: Delivering Therapeutics Across Biological Barriers”, introducing how the company’s technology platform enables innovative approaches to overcome biological barriers and improve drug delivery to the brain.

BioJapan 2025 provided a valuable environment to exchange ideas and foster partnerships that take science and medicines beyond frontiers.